In QuotedData’s morning briefing 3 July 2025: JPMorgan Global Growth and Income dividend to rise. Crystal Amber’s Morphic Medical gets EU approval. We also have: Did you see from yesterday?
Monks Investment Trust has published results covering the 12 months ended 30 April 2025. The trust was doing reasonably well ahead of ‘Liberation Day’ in early April. However, it was caught up in the resulting sell off and finished the year with an NAV return of just 0.1%. The discount widened from 8.5% to 10.1%, […]
Baker Steel says Polar Acquisition (which it has a 49.99% stake in) is selling its net smelter royalty related to the Prognoz silver project. The sale is for $11m in cash. Baker Steel’s look through share of that is $5.16m, which should arrive in Q3. The value of the royalty in the end May NAV […]
Schroder BSC Social Impact is considering its future after becoming frustrated with an inability to expand. The trust was launched in 2020 but a wide discount has prevented it from issuing more shares. The board says all strategic options to enhance value for the company’s shareholders are being considered, which could include a managed wind […]
In QuotedData’s morning briefing 2 July 2025: Diverse Income issued a reminder about its upcoming redemption opportunity. NB Distressed Debt’s chairman only just survived re-election. That seems to have spurred the trust into accelerating the trust’s liquidation. BioPharma Credit gets a bonus as another loan is repaid early. TR Property is going to broadcast its […]
Maven Renovar VCT’s board says it has received a letter from Paul Jourdan, shareholder and former manager of the portfolio, and a group of other shareholders seeking to convene a general meeting of the company to consider ordinary resolutions to remove the current board and appoint four replacement directors, including Paul Jourdan, in their place. […]
Secures NAV uplift from sale of vLex and adds to portfolio of lifestyle brands sale of vLex Oakley Capital Investments says legaltech platform vLex has been sold to Clio. The effect of the deal is to add 25p to the trust’s NAV or about 4% on the 31 March 2025 NAV. The trust’s share of […]
The NAV total return for Augmentum Fintech over the 12 months ended 31 March 2025 was -3.5%. The discount widened from 40.0% to 47.4%, leaving shareholders with a return of -15.4%. The chairman feels that it was a frustrating year. He says “our portfolio continues to deliver impressive operating performance, we have made two exciting […]
Geiger Counter’s interim results, covering the six-month period that ended on 31 March 2025, were published late yesterday. The NAV fell by 37.5% to 33.71p but, as the discount closed, the share price fell by 24.5%. During the period, the trust repurchased 7,989,430 shares at a cost of £3.9m. Since the end of March, a […]
CQS Natural Resources Growth and Income has survived its 100% tender offer. 29,334,059 shares (45.72% of the shares in issue) were tendered. A slice of the trust’s portfolio equating to 45.72% of its assets has been transferred into a ‘tender pool’. These assets will be liquidated and the cash handed back to the tendering shareholders. […]
